
DAVIDE PROSPERI
Principal Investigator of the NanoBioLab, Full Professor of Biochemistry
He is devoted to biomedical and biophysical applications of nanotechnology. In particular the design, synthesis, functionalization and characterization of colloidal, polymeric and biomimetic nanoparticles for biomedical applications, with particular focus on the diagnosis and treatment of cancer and inflammatory diseases.

MIRIAM COLOMBO
Principal Investigator of the NanoBioLab,
Associate Professor in Clinical Biochemistry

Lucia Salvioni
Assistant Professor in Clinical Biochemistry

Marco giustra
Assistant Professor in Pharmaceutical and Technological applications of Chemistry
Postdoctoral Fellows

LUCIA MORELLI

Stefania garbujo

Linda barbieri
Synthesis, characterization and functionalization of protein nanoparticles; isolation of mononuclear cells from whole blood; development of 3D cancer spheroids.
PhD STUDENTS
in Converging Technologies for Biomolecular Systems (TeCSBi)

Chiara baioni
pDNA and mRNA transfection studies; extracellular vesicles isolation and
characterization.

Filippo testa
PhD STUDENTS
in Marine Sciences, Technology and Management (MTM)

Francesca spena
Synthesis and characterization of polymer nanoparticles; nanoprecipitation and nano-encapsulation.

Beatrice De Santes
TECHNICIAN

Evelyn Ochoa
Senior technician

Giulia maffeo
Lab Manager
GRADUATE STUDENTS

Chiara colombo

Giulia Sinesi
COLLABORATORS from UNIMIB

Luisa fiandra
Assistant Professor in Clinical Biochemistry

Gianni frascotti
Tenured Assistant Professor in Chemistry and Biotechnology of Fermentation

Paolo Tortora
Senior Professor
His research project is aimed at employing the vault protein as a nanovector endowed with therapeutic efficacy, which is routinely produced in the laboratory using a yeast-based expression system. This molecule is been investigated in view of the development of vault-based nanovectors capable of delivering antitumor siRNAs or cytotoxic proteins to selected cancer cell lines.
Inversely, due to its ability to exert a cytoprotective action towards some cell
lines (notably cardiomyocytes), the possibility is being explored to use this same molecular assembly as a cytoprotective agent in patients treated with antitumor agents. For this purpose, the vault is equipped with antibodies or other proteins capable of specifically directing it to the target cells.

Metello Innocenti
Assistant Professor in Biochemistry
